Drug Database
Back to search

Denmark· DK-28103981506

Zymelin Plus

A xylometazoline product containing ipratropiumbromid, xylometazolinhydrochlorid, registered in Denmark by Orifarm Healthcare A/S. The same ATC class is registered in 10 of our 19 countries.

ATC R01AB06

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedZymelin PlusATCR01AB06REGISTER NO.DK-28103981506PACKS LISTED1CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ipratropiumbromid, xylometazolinhydrochloridAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Xylometazoline is registered in 10 of 19 countries.

Countries holding a registration under ATC R01AB06 (xylometazoline), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 7 of them publish a price we can compare per daily dose
Search xylometazoline products by name

Xylometazoline · ATC R01AB06

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
IPRATROPIUMBROMID, Xylometazolinhydrochlorid
Manufacturer
Orifarm Healthcare A/S
Country
Denmark (DK)
ATC code
R01AB06
ATC class
Xylometazoline
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28103981506

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

63 interactions on record for xylometazoline.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check xylometazoline against other medicinesHow interaction checks work

Xylometazoline · interactions on record

63 records

  • 6 severe
  • 54 moderate

Most severe, free to view

  • MethylergometrineG02AB01severe
  • DihydroergotamineN02CA01severe
  • ErgotamineN02CA02severe
  • MethysergideN02CA04severe

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under R01AB06

Xylometazoline, as other registers publish it.

All xylometazoline products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fe65e75c-5a98-4933-b8c7-8213b87bf2c5
GET /v1/drugs/fe65e75c-5a98-4933-b8c7-8213b87bf2c5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "næsespray, opløsning",
  "source": "dkma",
  "strength": "0,6 mg/ml+0,5 mg/ml",
  "auth_role": "CMS",
  "dk_drugid": "28103981506",
  "substance": "IPRATROPIUMBROMID, Xylometazolinhydrochlorid",
  "auth_procedure": "MRP",
  "in_medicinpriser": false,
  "registration_date_serial": "39087"
}
API referenceMCP serverPlans

See everything about xylometazoline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console